Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Jun

Showing results (181-190 of 230) with videos related to

Pageof 23
Sort By:
Molecules (Basel, Switzerland)|April 10, 2019
In Vitro and In Silico Acetylcholinesterase Inhibitory Activity of Thalictricavine and Canadine and Their Predicted Penetration across the Blood-Brain BarrierJakub Chlebek, Jan Korábečný, Rafael Doležal, et al.
ACS Medicinal Chemistry Letters|January 16, 2020
Cysteine-Targeted Insecticides against <i>A. gambiae</i> Acetylcholinesterase Are Neither Selective nor Reversible InhibitorsLukas Gorecki, Rudolf Andrys, Monika Schmidt, et al.
Molecules (Basel, Switzerland)|December 4, 2010
Synthesis and in vitro evaluation of N-(Bromobut-3-en-2-yl)-7-methoxy-1,2,3,4-tetrahydroacridin-9-amine as a cholinesterase inhibitor with regard to Alzheimer's disease treatmentJan Korabecny, Kamil Musilek, Ondrej Holas, et al.
Phytochemistry|July 2, 2019
Amaryllidaceae alkaloids from Narcissus pseudonarcissus L. cv. Dutch Master as potential drugs in treatment of Alzheimer's diseaseDaniela Hulcová, Jana Maříková, Jan Korábečný, et al.
Journal of Natural Products|February 1, 2019
Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's DiseaseAnna Hostalkova, Jana Marikova, Lubomir Opletal, et al.
Chemmedchem|October 3, 2015
Design, Synthesis and in vitro Evaluation of Indolotacrine Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's DiseaseOndrej Benek, Ondrej Soukup, Marketa Pasdiorova, et al.
Molecules (Basel, Switzerland)|June 17, 2017
Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer's Agents: Design, Synthesis and Biological EvaluationKatarina Spilovska, Jan Korabecny, Vendula Sepsova, et al.
Molecules (Basel, Switzerland)|May 9, 2018
Synthesis, Biological Evaluation, and Docking Studies of Novel Bisquaternary Aldoxime Reactivators on Acetylcholinesterase and Butyrylcholinesterase Inhibited by ParaoxonKamil Kuca, Daniel Jun, Lucie Junova, et al.
Current Alzheimer Research|March 16, 2019
N-alkylated Tacrine Derivatives as Potential Agents in Alzheimer's Disease TherapyEugenie Nepovimova, Jan Korabecny, Vendula Hepnarova, et al.
Molecules (Basel, Switzerland)|December 23, 2015
7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer's Disease TreatmentJan Korabecny, Martin Andrs, Eugenie Nepovimova, et al.
Pageof 23

Showing results (181-190 of 230) with videos related to

Sort By:
Pageof 23
Molecules (Basel, Switzerland)|April 10, 2019
In Vitro and In Silico Acetylcholinesterase Inhibitory Activity of Thalictricavine and Canadine and Their Predicted Penetration across the Blood-Brain BarrierJakub Chlebek, Jan Korábečný, Rafael Doležal, et al.
ACS Medicinal Chemistry Letters|January 16, 2020
Cysteine-Targeted Insecticides against <i>A. gambiae</i> Acetylcholinesterase Are Neither Selective nor Reversible InhibitorsLukas Gorecki, Rudolf Andrys, Monika Schmidt, et al.
Molecules (Basel, Switzerland)|December 4, 2010
Synthesis and in vitro evaluation of N-(Bromobut-3-en-2-yl)-7-methoxy-1,2,3,4-tetrahydroacridin-9-amine as a cholinesterase inhibitor with regard to Alzheimer's disease treatmentJan Korabecny, Kamil Musilek, Ondrej Holas, et al.
Phytochemistry|July 2, 2019
Amaryllidaceae alkaloids from Narcissus pseudonarcissus L. cv. Dutch Master as potential drugs in treatment of Alzheimer's diseaseDaniela Hulcová, Jana Maříková, Jan Korábečný, et al.
Journal of Natural Products|February 1, 2019
Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's DiseaseAnna Hostalkova, Jana Marikova, Lubomir Opletal, et al.
Chemmedchem|October 3, 2015
Design, Synthesis and in vitro Evaluation of Indolotacrine Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's DiseaseOndrej Benek, Ondrej Soukup, Marketa Pasdiorova, et al.
Molecules (Basel, Switzerland)|June 17, 2017
Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer's Agents: Design, Synthesis and Biological EvaluationKatarina Spilovska, Jan Korabecny, Vendula Sepsova, et al.
Molecules (Basel, Switzerland)|May 9, 2018
Synthesis, Biological Evaluation, and Docking Studies of Novel Bisquaternary Aldoxime Reactivators on Acetylcholinesterase and Butyrylcholinesterase Inhibited by ParaoxonKamil Kuca, Daniel Jun, Lucie Junova, et al.
Current Alzheimer Research|March 16, 2019
N-alkylated Tacrine Derivatives as Potential Agents in Alzheimer's Disease TherapyEugenie Nepovimova, Jan Korabecny, Vendula Hepnarova, et al.
Molecules (Basel, Switzerland)|December 23, 2015
7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer's Disease TreatmentJan Korabecny, Martin Andrs, Eugenie Nepovimova, et al.
Pageof 23